{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:21:54Z","timestamp":1740144114979,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s40266-023-01063-z","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T09:02:50Z","timestamp":1695805370000},"page":"1037-1045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The PROMISING Project: A Pilot Study to Improve Geriatric Care Through a Pharmacist-Led Psychotropic Stewardship Program"],"prefix":"10.1007","volume":"40","author":[{"given":"Marie","family":"d\u2019Amours","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Ettis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauriane","family":"Ginefri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela-Sinlan","family":"Lin Poo Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Wazzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3360-4831","authenticated-orcid":false,"given":"David","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8526-857X","authenticated-orcid":false,"given":"Vincent","family":"Dagenais-Beaul\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"1063_CR1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199911040-00003","author":"M Woodward","year":"1999","unstructured":"Woodward M. Hypnosedatives in the elderly. CNS Drugs. 1999. https:\/\/doi.org\/10.2165\/00023210-199911040-00003.","journal-title":"CNS Drugs"},{"key":"1063_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.07.024","author":"M Markota","year":"2016","unstructured":"Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine use in older adults: dangers, management, and alternative therapies. Mayo Clin Proc. 2016. https:\/\/doi.org\/10.1016\/j.mayocp.2016.07.024.","journal-title":"Mayo Clin Proc"},{"key":"1063_CR3","doi-asserted-by":"publisher","DOI":"10.4103\/2348-9995.161377","author":"N Kate","year":"2015","unstructured":"Kate N, Pawar S, Parkar S, Sawant N. Adverse drug reactions due to antipsychotics and sedative-hypnotics in the elderly. J Geriatr Ment Health. 2015. https:\/\/doi.org\/10.4103\/2348-9995.161377.","journal-title":"J Geriatr Ment Health"},{"key":"1063_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.15.1934","author":"LS Schneider","year":"2005","unstructured":"Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005. https:\/\/doi.org\/10.1001\/jama.294.15.1934.","journal-title":"JAMA"},{"key":"1063_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003476.pub2","author":"CG Ballard","year":"2006","unstructured":"Ballard CG, Waite J, Birks J. Atypical antipsychotics for aggression and psychosis in Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2006. https:\/\/doi.org\/10.1002\/14651858.CD003476.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1063_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2017.12.098","author":"LJ Seppala","year":"2018","unstructured":"Seppala LJ, Wermelink A, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018. https:\/\/doi.org\/10.1016\/j.jamda.2017.12.098.","journal-title":"J Am Med Dir Assoc"},{"key":"1063_CR7","doi-asserted-by":"publisher","unstructured":"Panel BtAGSBCUE. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019. https:\/\/doi.org\/10.1111\/jgs.15767.","DOI":"10.1111\/jgs.15767"},{"key":"1063_CR8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201800321","author":"DT Maust","year":"2019","unstructured":"Maust DT, Lin LA, Blow FC. Benzodiazepine use and misuse among adults in the United States. Psychiatr Serv. 2019. https:\/\/doi.org\/10.1176\/appi.ps.201800321.","journal-title":"Psychiatr Serv"},{"key":"1063_CR9","unstructured":"NSW Therapeutic Advisory Group. Deprescribing tools. In: NSW Therapeutic Advisory Group Inc. 2021. https:\/\/www.nswtag.org.au\/deprescribing-tools\/. Accessed 10 Dec 2022."},{"key":"1063_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.08.027","author":"B Cossette","year":"2020","unstructured":"Cossette B, Bruneau MA, Couturier Y, Gilbert S, Boyer D, Ricard J, et al. Optimizing practices, use, care and services-antipsychotics (OPUS-AP) in long-term care centers in Qu\u00e9bec, Canada: a strategy for best practices. J Am Med Dir Assoc. 2020. https:\/\/doi.org\/10.1016\/j.jamda.2019.08.027.","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"1063_CR11","first-page":"339","volume":"64","author":"K Pottie","year":"2018","unstructured":"Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Phys. 2018;64(5):339\u201351.","journal-title":"Can Fam Phys"},{"issue":"1","key":"1063_CR12","first-page":"17","volume":"64","author":"LM Bjerre","year":"2018","unstructured":"Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Phys. 2018;64(1):17\u201327.","journal-title":"Can Fam Phys"},{"key":"1063_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/2045125317743651","author":"SJC Davies","year":"2018","unstructured":"Davies SJC, Jacob B, Rudoler D, Zaheer J, de Oliveira C, Kurdyak P. Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013. Ther Adv Psychopharmacol. 2018. https:\/\/doi.org\/10.1177\/2045125317743651.","journal-title":"Ther Adv Psychopharmacol."},{"key":"1063_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-015-3501-5","author":"DC Scales","year":"2016","unstructured":"Scales DC, Fischer HD, Li P, Bierman AS, Fernandes O, Mamdani M, et al. Unintentional continuation of medications intended for acute illness after hospital discharge: a population-based cohort study. J Gen Intern Med. 2016. https:\/\/doi.org\/10.1007\/s11606-015-3501-5.","journal-title":"J Gen Intern Med"},{"key":"1063_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2277","author":"KP Loh","year":"2014","unstructured":"Loh KP, Ramdass S, Garb JL, Brennan MJ, Lindenauer PK, Lagu T. From hospital to community: use of antipsychotics in hospitalized elders. J Hosp Med. 2014. https:\/\/doi.org\/10.1002\/jhm.2277.","journal-title":"J Hosp Med"},{"key":"1063_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-019-00866-8","author":"LM Kalisch Ellett","year":"2019","unstructured":"Kalisch Ellett LM, Pratt NL, Apajee J, Roughead EE. Initiation and continuation of antipsychotic medicines in older people following non-psychiatric hospital admission. Int J Clin Pharm. 2019. https:\/\/doi.org\/10.1007\/s11096-019-00866-8.","journal-title":"Int J Clin Pharm"},{"key":"1063_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-018-0972-3","author":"E Bourcier","year":"2018","unstructured":"Bourcier E, Baptiste A, Borowik A, Zerbib L, Bonnet-Zamponi D, Tubach F, et al. Sedative-hypnotic initiation and renewal at discharge in hospitalized older patients: an observational study. BMC Geriatr. 2018. https:\/\/doi.org\/10.1186\/s12877-018-0972-3.","journal-title":"BMC Geriatr."},{"key":"1063_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu542","author":"LA Pollack","year":"2014","unstructured":"Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014. https:\/\/doi.org\/10.1093\/cid\/ciu542.","journal-title":"Clin Infect Dis"},{"key":"1063_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ajag.12501","author":"OA Pellicano","year":"2018","unstructured":"Pellicano OA, Tong E, Yip G, Monk L, Loh X, Ananda-Rajah M, et al. Geriatric Psychotropic Stewardship Team to de-escalate inappropriate psychotropic medications in general medicine inpatients: an evaluation. Australas J Ageing. 2018. https:\/\/doi.org\/10.1111\/ajag.12501.","journal-title":"Australas J Ageing"},{"key":"1063_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/0897190019830518","author":"NL Kovacic","year":"2020","unstructured":"Kovacic NL, Gagnon DJ, Riker RR, Wen S, Fraser GL. An analysis of psychoactive medications initiated in the ICU but continued beyond discharge: a pilot study of stewardship. J Pharm Pract. 2020. https:\/\/doi.org\/10.1177\/0897190019830518.","journal-title":"J Pharm Pract"},{"key":"1063_CR21","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2023.04.036","author":"RJ Haight","year":"2023","unstructured":"Haight RJ, Di Polito CN, Payne GH, Bostwick JR, Fulbright A, Lister JF, et al. Psychotropic stewardship: advancing patient care. Ment Health Clin. 2023. https:\/\/doi.org\/10.9740\/mhc.2023.04.036.","journal-title":"Ment Health Clin."},{"key":"1063_CR22","doi-asserted-by":"publisher","DOI":"10.1086\/678057","author":"B Wagner","year":"2014","unstructured":"Wagner B, Filice GA, Drekonja D, Greer N, MacDonald R, Rutks I, et al. Antimicrobial stewardship programs in inpatient hospital settings: a systematic review. Infect Control Hosp Epidemiol. 2014. https:\/\/doi.org\/10.1086\/678057.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1063_CR23","unstructured":"Canadian Medication Appropriatement and Deprescribing Network. Deprescribing algorithms. In: The Canadian Medication Appropriateness and Deprescribing Network. 2017. https:\/\/www.deprescribingnetwork.ca. Accessed 10 Dec 2022."},{"key":"1063_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/add.15997","author":"A Soni","year":"2023","unstructured":"Soni A, Thiyagarajan A, Reeve J. Feasibility and effectiveness of deprescribing benzodiazepines and Z-drugs: systematic review and meta-analysis. Addiction. 2023. https:\/\/doi.org\/10.1111\/add.15997.","journal-title":"Addiction"},{"key":"1063_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5383","author":"E Gosselin","year":"2022","unstructured":"Gosselin E, Simard M, Lunghi C, Sirois C. Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada. Pharmacoepidemiol Drug Saf. 2022. https:\/\/doi.org\/10.1002\/pds.5383.","journal-title":"Pharmacoepidemiol Drug Saf."}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01063-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:19:55Z","timestamp":1698229195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01063-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01063-z","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"type":"print","value":"1170-229X"},{"type":"electronic","value":"1179-1969"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"22 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Funding was granted by the Faculty of Pharmacy of the University of Montreal for statistical analyses.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Marie d\u2019Amours, Farah Ettis, Lauriane Ginefri, Johnny Lim and Angela-Sinlan Lin Poo Yuan, Jennifer Fontaine, Dana Wazzan and David Williamson declare that they have no conflicts of interest. Vincent Dagenais-Beaul\u00e9 has received fees for consulting from Abbvie, HLS therapeutics and Otsuka for unrelated work, and speaker fees from Abbvie, HLS therapeutics, Ostuka and Jansen for unrelated work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The data generated and analyzed during the current study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study has been approved by the Quality, Transformation, Evaluation, Performance and Ethics Department of the CIUSSS West-Central Montreal. This quality improvement project falls under Article 2.5 of the TriCouncil Policy, statement 2, 2018 and therefore Research Ethics Board approval was not required. As quality improvement research, participants\u2019 consent was not required and access to their charts was granted by the Director of Professional Services of the institution. Patients enrolled were assigned an identification number by the pharmacy at the time of inclusion. Confidential information was anonymized and kept in a secured electronic file protected by a password, solely accessible by the stewardship pharmacists leading the project. The file was destroyed at the end of follow-up to preserve patients\u2019 confidentiality.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the study conception and design. Material preparation, data collection and analyses were performed by Marie d\u2019Amours, Farah Ettis, Lauriane Ginefri, Johnny Lim and Angela-Sinlan Lin Poo Yuan. The first draft of the manuscript was written by Marie d\u2019Amours, Farah Ettis, Lauriane Ginefri, Johnny Lim and Angela-Sinlan Lin Poo Yuan. All authors commented and edited the manuscript. All authors read and approved the final version of the manuscript and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}